Advanced SearchSearch Tips
Dicumarol Inhibits PMA-Induced MMP-9 Expression through NQO1-independent manner in Human Renal Carcinoma Caki Cells
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Life Science
  • Volume 26, Issue 2,  2016, pp.174-180
  • Publisher : Korean Society of Life Science
  • DOI : 10.5352/JLS.2016.26.2.174
 Title & Authors
Dicumarol Inhibits PMA-Induced MMP-9 Expression through NQO1-independent manner in Human Renal Carcinoma Caki Cells
Park, Eun Jung; Kwon, Taeg Kyu;
  PDF(new window)
Dicumarol is a coumarin derivative isolated from sweet clover (Melilotus alba), and has anti-coagulant activity with the inhibitory activity of NAD(P)H quinone oxidoreductase1 (NQO1). NQO1 catalyzes the two-electron reduction of quinones to hydroquinones. Dicumarol competes with NAD(P)H for binding to NQO1, resulting in the inhibition of NQO1 enzymatic activity. The expression of matrix metalloproteinases (MMPs) has been implicated in the invasion and metastasis of cancer cells. The expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate (PMA). However, the effects of dicumarol on metalloproteinase (MMP)-9 expression and activity are not investigated here. This study investigated whether dicumarol inhibits MMP-9 expression and activity in PMA-treated human renal carcinoma Caki cells. Dicumarol markedly inhibited the PMA-induced MMP-9 mRNA expression and MMP-9 activity. NF-κB and AP1 promoter activity, which is important in MMP-9 expression, also decreased in dicumarol-treated cells. Furthermore, dicumarol markedly suppressed the ability of PMA-mediated migration in Caki cells. When the relevance of NQO1 in the dicumarol-mediated inhibitory effect on PMA-induced MMP9 activity was elucidated, knock-down of NQO1 with siRNA was found to have no effect on PMA-induced MMP9 activity, suggesting that the stimulating effect of dicumarol on PMA-induced MMP9 activity is independent of NQO1 activity. Taken together, the present studies suggested that dicumarol may inhibit PMA-induced migration via down-regulation of MMP-9 expression and activity.
Caki cells;Dicumarol;Matrix metalloproteinase-9;NF-κB;NQO1 (NAD(P)H quinone oxidoreductase1);
 Cited by
Abdelmohsen, K., Stuhlmann, D., Daubrawa, F. and Klotz, L. O. 2005. Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication. Arch. Biochem. Biophys. 434, 241-247. crossref(new window)

Ahn, K. S., Sethi, G., Jain, A. K., Jaiswal, A. K. and Aggarwal, B. B. 2006. Genetic deletion of NAD(P)H:quinone oxidoreductase1 abrogates activation of nuclear factor-kappa B, Ikappa B alpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J. Biol. Chem. 281, 19798-19808. crossref(new window)

Amalinei, C., Caruntu, I. D. and Balan, R. A. 2007. Biology of metalloproteinases. Rom. J. Morphol. Embryol. 48, 323-334.

Asher, G., Dym, O., Tsvetkov, P., Adler, J. and Shaul, Y. 2006. The crystal structure of NAD(P)H quinone oxidoreductase1in complex with its potent inhibitor dicoumarol, Biochemistry 45, 6372-6378. crossref(new window)

Cullen, J. J., Hinkhouse, M. M., Grady, M., Gaut, A.W., Liu, J., Zhang, Y. P., Weydert, C. J., Domann, F. E. and Oberley, L.W. 2003. Dicumarol inhibition of NADPH:quinone oxidoreductase 1 induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 63, 5513-5520.

Festuccia, C., Giunciuglio, D., Guerra, F., Villanova, I., Angelucci, A., Manduca, P., Teti, A., Albini, A. and Bologna, M. 1999. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Oncol. Res. 11, 17-31.

Hansen, M. B., Nielsen, S. E. and Berg, K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210. crossref(new window)

Jung, J. S., Jung, K., Kim, D. H. and Kim, H. S. 2012. Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways. Pharmacol. Res. 66, 95-103. crossref(new window)

Kato, Y., Yamashita, T. and Ishikawa, M. 2002. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol. Rep. 9, 565-569.

Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. 2004. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198. crossref(new window)

Lee, S. O., Chang, Y. C., Whang, K., Kim, C. H. and Lee, I. S. 2007. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells. Cardiovasc. Res. 76, 331-339. crossref(new window)

Ling, H., Zhang, Y., Ng, K. Y. and Chew, E. H. 2011. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat. 126, 609-620. crossref(new window)

Matsunaga, Y., Koda, M. and Murawaki, Y. 2004. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Res. Commun. Mol. Pathol. Pharmacol. 115, 143-150.

Nolan, K. A., Scott, K. A., Barnes, J., Doncaster, J., Whitehead, R. C. and Stratford, I. J. 2010. Pharmacological inhibitors of NAD(P)Hquinone oxidoreductase, NQO1: structure /activity relationships and functional activity in tumour cells, Biochem.Pharmacol. 80, 977-981. crossref(new window)

Park, E. J., Choi, K. S. and Kwon, T. K. 2011. β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem. Biol. Interact. 189, 37-44. crossref(new window)

Park, E. J., Min, K. J., Choi, K. S. and Kwon, T. K. 2014. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner. Exp. Cell Res. 323, 144-154. crossref(new window)

Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L. and Quigley, J. P. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274, 13066-13076. crossref(new window)

Soreide, K., Janssen, E. A., Korner, H. and Baak, J. P. 2006. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J. Pathol. 209, 147-156. crossref(new window)

Uzui, H., Harpf, A., Liu, M., Doherty, T. M., Shukla, A. and Chai, N. 2002. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106, 3024-3030. crossref(new window)

Vasiliou, V., Ross, D. and Nebert, D. W. 2006. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum. Genomics 2, 329-335. crossref(new window)

Visse, R. and Nagase, H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839. crossref(new window)

Woo, J. H., Lim, J. H., Kim, Y. H., Suh, S. I., Min, D. S., Chang, J. S., Lee, Y. H., Park, J. W. and Kwon, T. K. 2004. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23, 1845-1853. crossref(new window)